Global Seroprevalence of Pre-existing Immunity Against AAV5 and Other AAV Serotypes in People with Hemophilia A

Klamroth, R; Hayes, G; Andreeva, T; Gregg, K; Suzuki, T; Mitha, IH; Hardesty, B; Shima, M; Pollock, T; Slev, P; Oldenburg, J; Ozelo, MC; Stieltjes, N; Castet, SM; Mahlangu, J; Peyvandi, F; Kazmi, R; Schved, JF; Leavitt, AD; Callaghan, M; Pan-Petesch, B; Quon, DV; Andrews, J; Trinh, A; Li, MJ; Wong, WY

Klamroth, R (通讯作者)，Vivantes Klinikum Friedrichshain, Comprehens Care Haemophilia Treatment Ctr, Landsberger Allee 49, D-10249 Berlin, Germany.

HUMAN GENE THERAPY, 2022; 33 (7-8): 432

Abstract

Adeno-associated virus (AAV)-mediated gene therapy may provide durable protection from bleeding events and reduce treatment burden for people with hem......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索